⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Phanes Therapeutics to Present Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting
prnewswire.com
MRK
Form 8-K
sec.gov
TENX
LNSR
BCRX
MRK
GILD
Merck and Google Cloud Partner to Accelerate Agentic AI Enterprise Transformation
prnewswire.com
MRK
GOOGL
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®
prnewswire.com
LH
AGNC
MRK
Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca
globenewswire.com
MRK
BMY
AZN
Connected Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032: Rising Demand for Telehealth Programs Integrated with AR and Virtual Reality VR Technologies
globenewswire.com
MDT
WST
MRK
NVO
TNDM
TEVA
BDC
Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting USA - English APAC - Traditional Chinese
prnewswire.com
MRK
冠科生物与 Turbine 达成战略合作伙伴关系，以 AI + 类器官技术赋能转化肿瘤学创新
businesswire.com
AZN
MRK
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)
businesswire.com
MRK
GILD
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
accessnewswire.com
MRK